The FinTech Hub
Source: Live Mint Sai Life Sciences Limited’s initial public offering (IPO), through a book-built issue, offers a combination of a fresh issue of equity shares amounting to ₹950 crore and an offer-for-sale (OFS) component of up to 3.81 crore equity shares. The ₹3,043 crore IPO opened for public subscription on Wednesday, December 11 and will…
Source: Live Mint IPOs this week: The primary market is set to remain active next week, with five mainboard companies and six SME companies preparing to launch their initial public offerings (IPOs). Ranging from fintechs to supermarket chains, these mainboard IPOs are expected to collectively raise over ₹19,000 crore, reflecting strong investor interest across diverse…
Source: Live Mint The initial public offering (IPO) of Sai Life Sciences, a prominent player in small-molecule drug development and manufacturing, is scheduled to open on Wednesday, December 11, 2024, and close on Friday, December 13, 2024. The IPO consists of a fresh issue worth ₹950 crore and an offer for sale (OFS) of 3.81…
